nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—Cladribine—multiple sclerosis	0.311	1	CrCtD
Fludarabine—RRM1—multiple sclerosis	0.209	1	CbGaD
Fludarabine—RRM1—Cladribine—multiple sclerosis	0.0725	0.307	CbGbCtD
Fludarabine—SLC28A3—Cladribine—multiple sclerosis	0.0626	0.265	CbGbCtD
Fludarabine—POLA1—Cladribine—multiple sclerosis	0.0626	0.265	CbGbCtD
Fludarabine—DCK—Cladribine—multiple sclerosis	0.0386	0.163	CbGbCtD
Fludarabine—Regadenoson—Cladribine—multiple sclerosis	0.0306	0.163	CrCrCtD
Fludarabine—Clofarabine—Cladribine—multiple sclerosis	0.0306	0.163	CrCrCtD
Fludarabine—Nelarabine—Cladribine—multiple sclerosis	0.0271	0.144	CrCrCtD
Fludarabine—Adenosine monophosphate—Cladribine—multiple sclerosis	0.0271	0.144	CrCrCtD
Fludarabine—Vidarabine—Cladribine—multiple sclerosis	0.0243	0.129	CrCrCtD
Fludarabine—Adenosine—Cladribine—multiple sclerosis	0.0243	0.129	CrCrCtD
Fludarabine—Azacitidine—Cladribine—multiple sclerosis	0.0243	0.129	CrCrCtD
Fludarabine—RRM1—Nucleotide Metabolism—SRM—multiple sclerosis	0.00127	0.232	CbGpPWpGaD
Fludarabine—S-Adenosylmethionine—SRM—multiple sclerosis	0.000894	0.597	CrCbGaD
Fludarabine—POLA1—Nucleotide Metabolism—SRM—multiple sclerosis	0.000716	0.131	CbGpPWpGaD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000399	0.0729	CbGpPWpGaD
Fludarabine—Clofarabine—RRM1—multiple sclerosis	0.000383	0.256	CrCbGaD
Fludarabine—POLA1—Nucleotide Metabolism—RRM1—multiple sclerosis	0.000382	0.0699	CbGpPWpGaD
Fludarabine—POLA1—retina—multiple sclerosis	0.000359	0.0972	CbGeAlD
Fludarabine—RRM1—retina—multiple sclerosis	0.000285	0.0771	CbGeAlD
Fludarabine—RRM1—Azacitidine—Cladribine—multiple sclerosis	0.000264	0.294	CbGdCrCtD
Fludarabine—DCK—retina—multiple sclerosis	0.000221	0.0599	CbGeAlD
Fludarabine—Cladribine—RRM1—multiple sclerosis	0.00022	0.147	CrCbGaD
Fludarabine—RRM1—medulla oblongata—multiple sclerosis	0.000206	0.0557	CbGeAlD
Fludarabine—RRM1—midbrain—multiple sclerosis	0.000188	0.0509	CbGeAlD
Fludarabine—RRM1—spinal cord—multiple sclerosis	0.000184	0.0497	CbGeAlD
Fludarabine—POLA1—cerebellum—multiple sclerosis	0.000183	0.0497	CbGeAlD
Fludarabine—DCK—Nucleotide metabolism—RRM1—multiple sclerosis	0.000169	0.0308	CbGpPWpGaD
Fludarabine—DCK—medulla oblongata—multiple sclerosis	0.00016	0.0433	CbGeAlD
Fludarabine—RRM1—nervous system—multiple sclerosis	0.000155	0.0419	CbGeAlD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.000155	0.0283	CbGpPWpGaD
Fludarabine—POLA1—brain—multiple sclerosis	0.000149	0.0403	CbGeAlD
Fludarabine—RRM1—central nervous system—multiple sclerosis	0.000149	0.0403	CbGeAlD
Fludarabine—DCK—midbrain—multiple sclerosis	0.000146	0.0396	CbGeAlD
Fludarabine—SLC28A3—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000146	0.0266	CbGpPWpGaD
Fludarabine—RRM1—cerebellum—multiple sclerosis	0.000146	0.0394	CbGeAlD
Fludarabine—DCK—spinal cord—multiple sclerosis	0.000143	0.0386	CbGeAlD
Fludarabine—POLA1—E2F transcription factor network—RRM1—multiple sclerosis	0.00013	0.0238	CbGpPWpGaD
Fludarabine—SLC28A3—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.000129	0.0236	CbGpPWpGaD
Fludarabine—SLC29A1—nervous system—multiple sclerosis	0.000126	0.0341	CbGeAlD
Fludarabine—SLC29A1—central nervous system—multiple sclerosis	0.000121	0.0328	CbGeAlD
Fludarabine—DCK—nervous system—multiple sclerosis	0.00012	0.0325	CbGeAlD
Fludarabine—SLC29A1—cerebellum—multiple sclerosis	0.000118	0.032	CbGeAlD
Fludarabine—RRM1—brain—multiple sclerosis	0.000118	0.032	CbGeAlD
Fludarabine—DCK—central nervous system—multiple sclerosis	0.000116	0.0313	CbGeAlD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.000113	0.0207	CbGpPWpGaD
Fludarabine—DCK—cerebellum—multiple sclerosis	0.000113	0.0306	CbGeAlD
Fludarabine—SLC28A3—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00011	0.0202	CbGpPWpGaD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000109	0.0199	CbGpPWpGaD
Fludarabine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	9.65e-05	0.0176	CbGpPWpGaD
Fludarabine—SLC29A1—brain—multiple sclerosis	9.62e-05	0.026	CbGeAlD
Fludarabine—DCK—brain—multiple sclerosis	9.19e-05	0.0249	CbGeAlD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	8.24e-05	0.015	CbGpPWpGaD
Fludarabine—SLC28A3—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	7.72e-05	0.0141	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.41e-05	0.0135	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	6.03e-05	0.011	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	5.87e-05	0.0107	CbGpPWpGaD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	5.75e-05	0.0105	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.61e-05	0.0103	CbGpPWpGaD
Fludarabine—DCK—Desoximetasone—Methylprednisolone—multiple sclerosis	5.6e-05	0.0625	CbGdCrCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.52e-05	0.0101	CbGpPWpGaD
Fludarabine—DCK—Desoximetasone—Dexamethasone—multiple sclerosis	5.51e-05	0.0615	CbGdCrCtD
Fludarabine—DCK—Desoximetasone—Betamethasone—multiple sclerosis	5.51e-05	0.0615	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Methylprednisolone—multiple sclerosis	5.44e-05	0.0606	CbGdCrCtD
Fludarabine—DCK—Desoximetasone—Triamcinolone—multiple sclerosis	5.39e-05	0.0601	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Betamethasone—multiple sclerosis	5.35e-05	0.0597	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Dexamethasone—multiple sclerosis	5.35e-05	0.0597	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Triamcinolone—multiple sclerosis	5.23e-05	0.0583	CbGdCrCtD
Fludarabine—DCK—Desoximetasone—Prednisone—multiple sclerosis	5.11e-05	0.057	CbGdCrCtD
Fludarabine—DCK—Desoximetasone—Prednisolone—multiple sclerosis	4.99e-05	0.0556	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Prednisone—multiple sclerosis	4.96e-05	0.0553	CbGdCrCtD
Fludarabine—DCK—Diflorasone—Prednisolone—multiple sclerosis	4.84e-05	0.054	CbGdCrCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	4.71e-05	0.00861	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.44e-05	0.00811	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.19e-05	0.00765	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.03e-05	0.00737	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—MYC—multiple sclerosis	3.97e-05	0.00725	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.92e-05	0.00717	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SRM—multiple sclerosis	3.73e-05	0.00682	CbGpPWpGaD
Fludarabine—Ill-defined disorder—Prednisolone—multiple sclerosis	3.66e-05	0.00084	CcSEcCtD
Fludarabine—Visual impairment—Betamethasone—multiple sclerosis	3.64e-05	0.000836	CcSEcCtD
Fludarabine—Visual impairment—Dexamethasone—multiple sclerosis	3.64e-05	0.000836	CcSEcCtD
Fludarabine—Malnutrition—Methylprednisolone—multiple sclerosis	3.62e-05	0.000831	CcSEcCtD
Fludarabine—Acute coronary syndrome—Prednisone—multiple sclerosis	3.62e-05	0.00083	CcSEcCtD
Fludarabine—Neuropathy peripheral—Prednisone—multiple sclerosis	3.6e-05	0.000825	CcSEcCtD
Fludarabine—Myocardial infarction—Prednisone—multiple sclerosis	3.6e-05	0.000825	CcSEcCtD
Fludarabine—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	3.58e-05	0.000822	CcSEcCtD
Fludarabine—Hypersensitivity—Azathioprine—multiple sclerosis	3.58e-05	0.000821	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	3.57e-05	0.00082	CcSEcCtD
Fludarabine—Malaise—Prednisolone—multiple sclerosis	3.56e-05	0.000816	CcSEcCtD
Fludarabine—Nausea—Cladribine—multiple sclerosis	3.55e-05	0.000814	CcSEcCtD
Fludarabine—Paraesthesia—Mitoxantrone—multiple sclerosis	3.52e-05	0.000809	CcSEcCtD
Fludarabine—Dyspnoea—Mitoxantrone—multiple sclerosis	3.5e-05	0.000803	CcSEcCtD
Fludarabine—Dyspepsia—Mitoxantrone—multiple sclerosis	3.45e-05	0.000793	CcSEcCtD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	3.45e-05	0.0063	CbGpPWpGaD
Fludarabine—Convulsion—Prednisolone—multiple sclerosis	3.42e-05	0.000784	CcSEcCtD
Fludarabine—Decreased appetite—Mitoxantrone—multiple sclerosis	3.41e-05	0.000783	CcSEcCtD
Fludarabine—Fatigue—Mitoxantrone—multiple sclerosis	3.38e-05	0.000776	CcSEcCtD
Fludarabine—Arrhythmia—Dexamethasone—multiple sclerosis	3.38e-05	0.000775	CcSEcCtD
Fludarabine—Arrhythmia—Betamethasone—multiple sclerosis	3.38e-05	0.000775	CcSEcCtD
Fludarabine—Ill-defined disorder—Triamcinolone—multiple sclerosis	3.37e-05	0.000772	CcSEcCtD
Fludarabine—Ill-defined disorder—Methylprednisolone—multiple sclerosis	3.36e-05	0.000771	CcSEcCtD
Fludarabine—Pain—Mitoxantrone—multiple sclerosis	3.36e-05	0.00077	CcSEcCtD
Fludarabine—Constipation—Mitoxantrone—multiple sclerosis	3.36e-05	0.00077	CcSEcCtD
Fludarabine—Alopecia—Dexamethasone—multiple sclerosis	3.34e-05	0.000767	CcSEcCtD
Fludarabine—Alopecia—Betamethasone—multiple sclerosis	3.34e-05	0.000767	CcSEcCtD
Fludarabine—Diarrhoea—Azathioprine—multiple sclerosis	3.32e-05	0.000762	CcSEcCtD
Fludarabine—Discomfort—Prednisolone—multiple sclerosis	3.32e-05	0.000761	CcSEcCtD
Fludarabine—Haemoglobin—Prednisone—multiple sclerosis	3.31e-05	0.000759	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.31e-05	0.00604	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	3.31e-05	0.00604	CbGpPWpGaD
Fludarabine—Haemorrhage—Prednisone—multiple sclerosis	3.29e-05	0.000756	CcSEcCtD
Fludarabine—Malaise—Triamcinolone—multiple sclerosis	3.27e-05	0.000751	CcSEcCtD
Fludarabine—Pancytopenia—Methotrexate—multiple sclerosis	3.26e-05	0.000749	CcSEcCtD
Fludarabine—Malaise—Methylprednisolone—multiple sclerosis	3.26e-05	0.000749	CcSEcCtD
Fludarabine—Feeling abnormal—Mitoxantrone—multiple sclerosis	3.23e-05	0.000742	CcSEcCtD
Fludarabine—Anaphylactic shock—Prednisolone—multiple sclerosis	3.22e-05	0.000739	CcSEcCtD
Fludarabine—Oedema—Prednisolone—multiple sclerosis	3.22e-05	0.000739	CcSEcCtD
Fludarabine—Neutropenia—Methotrexate—multiple sclerosis	3.21e-05	0.000738	CcSEcCtD
Fludarabine—Dysuria—Methotrexate—multiple sclerosis	3.21e-05	0.000738	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Methotrexate—multiple sclerosis	3.2e-05	0.000733	CcSEcCtD
Fludarabine—Cough—Triamcinolone—multiple sclerosis	3.17e-05	0.000726	CcSEcCtD
Fludarabine—Convulsion—Triamcinolone—multiple sclerosis	3.14e-05	0.000721	CcSEcCtD
Fludarabine—Convulsion—Methylprednisolone—multiple sclerosis	3.14e-05	0.00072	CcSEcCtD
Fludarabine—Hyperhidrosis—Prednisolone—multiple sclerosis	3.11e-05	0.000714	CcSEcCtD
Fludarabine—Body temperature increased—Mitoxantrone—multiple sclerosis	3.1e-05	0.000712	CcSEcCtD
Fludarabine—Myalgia—Triamcinolone—multiple sclerosis	3.09e-05	0.000709	CcSEcCtD
Fludarabine—Vomiting—Azathioprine—multiple sclerosis	3.09e-05	0.000708	CcSEcCtD
Fludarabine—Pneumonia—Methotrexate—multiple sclerosis	3.08e-05	0.000708	CcSEcCtD
Fludarabine—Arthralgia—Methylprednisolone—multiple sclerosis	3.08e-05	0.000707	CcSEcCtD
Fludarabine—Myalgia—Methylprednisolone—multiple sclerosis	3.08e-05	0.000707	CcSEcCtD
Fludarabine—Rash—Azathioprine—multiple sclerosis	3.06e-05	0.000702	CcSEcCtD
Fludarabine—Dermatitis—Azathioprine—multiple sclerosis	3.06e-05	0.000702	CcSEcCtD
Fludarabine—Ill-defined disorder—Dexamethasone—multiple sclerosis	3.05e-05	0.000701	CcSEcCtD
Fludarabine—Ill-defined disorder—Betamethasone—multiple sclerosis	3.05e-05	0.000701	CcSEcCtD
Fludarabine—Discomfort—Triamcinolone—multiple sclerosis	3.05e-05	0.0007	CcSEcCtD
Fludarabine—Discomfort—Methylprednisolone—multiple sclerosis	3.04e-05	0.000699	CcSEcCtD
Fludarabine—Headache—Azathioprine—multiple sclerosis	3.04e-05	0.000698	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	3.04e-05	0.000697	CcSEcCtD
Fludarabine—Renal failure—Methotrexate—multiple sclerosis	3.01e-05	0.000691	CcSEcCtD
Fludarabine—Stomatitis—Methotrexate—multiple sclerosis	2.99e-05	0.000686	CcSEcCtD
Fludarabine—Confusional state—Methylprednisolone—multiple sclerosis	2.98e-05	0.000683	CcSEcCtD
Fludarabine—Malaise—Betamethasone—multiple sclerosis	2.97e-05	0.000681	CcSEcCtD
Fludarabine—Malaise—Dexamethasone—multiple sclerosis	2.97e-05	0.000681	CcSEcCtD
Fludarabine—Anaphylactic shock—Triamcinolone—multiple sclerosis	2.96e-05	0.000679	CcSEcCtD
Fludarabine—Oedema—Triamcinolone—multiple sclerosis	2.96e-05	0.000679	CcSEcCtD
Fludarabine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	2.95e-05	0.000678	CcSEcCtD
Fludarabine—Arrhythmia—Prednisone—multiple sclerosis	2.94e-05	0.000675	CcSEcCtD
Fludarabine—Infection—Triamcinolone—multiple sclerosis	2.94e-05	0.000675	CcSEcCtD
Fludarabine—Infection—Methylprednisolone—multiple sclerosis	2.93e-05	0.000673	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.92e-05	0.00534	CbGpPWpGaD
Fludarabine—Haematuria—Methotrexate—multiple sclerosis	2.92e-05	0.000671	CcSEcCtD
Fludarabine—Alopecia—Prednisone—multiple sclerosis	2.91e-05	0.000668	CcSEcCtD
Fludarabine—Nervous system disorder—Methylprednisolone—multiple sclerosis	2.9e-05	0.000665	CcSEcCtD
Fludarabine—Epistaxis—Methotrexate—multiple sclerosis	2.89e-05	0.000664	CcSEcCtD
Fludarabine—Hypersensitivity—Mitoxantrone—multiple sclerosis	2.89e-05	0.000663	CcSEcCtD
Fludarabine—Paraesthesia—Prednisolone—multiple sclerosis	2.89e-05	0.000663	CcSEcCtD
Fludarabine—Nausea—Azathioprine—multiple sclerosis	2.88e-05	0.000662	CcSEcCtD
Fludarabine—DCK—Metabolism—SRM—multiple sclerosis	2.87e-05	0.00525	CbGpPWpGaD
Fludarabine—Malnutrition—Prednisone—multiple sclerosis	2.87e-05	0.000658	CcSEcCtD
Fludarabine—Hyperhidrosis—Triamcinolone—multiple sclerosis	2.86e-05	0.000657	CcSEcCtD
Fludarabine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	2.86e-05	0.000655	CcSEcCtD
Fludarabine—Convulsion—Dexamethasone—multiple sclerosis	2.85e-05	0.000654	CcSEcCtD
Fludarabine—Convulsion—Betamethasone—multiple sclerosis	2.85e-05	0.000654	CcSEcCtD
Fludarabine—Asthenia—Mitoxantrone—multiple sclerosis	2.82e-05	0.000646	CcSEcCtD
Fludarabine—Myalgia—Betamethasone—multiple sclerosis	2.8e-05	0.000643	CcSEcCtD
Fludarabine—Myalgia—Dexamethasone—multiple sclerosis	2.8e-05	0.000643	CcSEcCtD
Fludarabine—SLC28A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.78e-05	0.00508	CbGpPWpGaD
Fludarabine—Discomfort—Dexamethasone—multiple sclerosis	2.77e-05	0.000635	CcSEcCtD
Fludarabine—Discomfort—Betamethasone—multiple sclerosis	2.77e-05	0.000635	CcSEcCtD
Fludarabine—Haemoglobin—Methotrexate—multiple sclerosis	2.77e-05	0.000635	CcSEcCtD
Fludarabine—Pain—Prednisolone—multiple sclerosis	2.75e-05	0.000632	CcSEcCtD
Fludarabine—Haemorrhage—Methotrexate—multiple sclerosis	2.75e-05	0.000631	CcSEcCtD
Fludarabine—Pharyngitis—Methotrexate—multiple sclerosis	2.73e-05	0.000627	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	2.7e-05	0.000619	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	2.69e-05	0.000618	CcSEcCtD
Fludarabine—Oedema—Dexamethasone—multiple sclerosis	2.69e-05	0.000616	CcSEcCtD
Fludarabine—Anaphylactic shock—Betamethasone—multiple sclerosis	2.69e-05	0.000616	CcSEcCtD
Fludarabine—Oedema—Betamethasone—multiple sclerosis	2.69e-05	0.000616	CcSEcCtD
Fludarabine—Anaphylactic shock—Dexamethasone—multiple sclerosis	2.69e-05	0.000616	CcSEcCtD
Fludarabine—Diarrhoea—Mitoxantrone—multiple sclerosis	2.68e-05	0.000616	CcSEcCtD
Fludarabine—Infection—Dexamethasone—multiple sclerosis	2.67e-05	0.000612	CcSEcCtD
Fludarabine—Infection—Betamethasone—multiple sclerosis	2.67e-05	0.000612	CcSEcCtD
Fludarabine—Ill-defined disorder—Prednisone—multiple sclerosis	2.66e-05	0.00061	CcSEcCtD
Fludarabine—Paraesthesia—Triamcinolone—multiple sclerosis	2.66e-05	0.00061	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.65e-05	0.00485	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	2.65e-05	0.00485	CbGpPWpGaD
Fludarabine—Feeling abnormal—Prednisolone—multiple sclerosis	2.65e-05	0.000609	CcSEcCtD
Fludarabine—Paraesthesia—Methylprednisolone—multiple sclerosis	2.65e-05	0.000609	CcSEcCtD
Fludarabine—Visual impairment—Methotrexate—multiple sclerosis	2.65e-05	0.000609	CcSEcCtD
Fludarabine—Anaemia—Prednisone—multiple sclerosis	2.65e-05	0.000608	CcSEcCtD
Fludarabine—Dyspnoea—Triamcinolone—multiple sclerosis	2.64e-05	0.000606	CcSEcCtD
Fludarabine—Nervous system disorder—Dexamethasone—multiple sclerosis	2.63e-05	0.000605	CcSEcCtD
Fludarabine—Nervous system disorder—Betamethasone—multiple sclerosis	2.63e-05	0.000605	CcSEcCtD
Fludarabine—Agitation—Prednisone—multiple sclerosis	2.63e-05	0.000604	CcSEcCtD
Fludarabine—Thrombocytopenia—Betamethasone—multiple sclerosis	2.63e-05	0.000604	CcSEcCtD
Fludarabine—Thrombocytopenia—Dexamethasone—multiple sclerosis	2.63e-05	0.000604	CcSEcCtD
Fludarabine—RRM1—Metabolism—CYP24A1—multiple sclerosis	2.63e-05	0.0048	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP27B1—multiple sclerosis	2.63e-05	0.0048	CbGpPWpGaD
Fludarabine—Dyspepsia—Triamcinolone—multiple sclerosis	2.61e-05	0.000598	CcSEcCtD
Fludarabine—Erythema multiforme—Methotrexate—multiple sclerosis	2.6e-05	0.000597	CcSEcCtD
Fludarabine—Dyspepsia—Methylprednisolone—multiple sclerosis	2.6e-05	0.000597	CcSEcCtD
Fludarabine—Hyperhidrosis—Dexamethasone—multiple sclerosis	2.6e-05	0.000596	CcSEcCtD
Fludarabine—Hyperhidrosis—Betamethasone—multiple sclerosis	2.6e-05	0.000596	CcSEcCtD
Fludarabine—Malaise—Prednisone—multiple sclerosis	2.58e-05	0.000593	CcSEcCtD
Fludarabine—Anorexia—Dexamethasone—multiple sclerosis	2.56e-05	0.000588	CcSEcCtD
Fludarabine—Anorexia—Betamethasone—multiple sclerosis	2.56e-05	0.000588	CcSEcCtD
Fludarabine—Fatigue—Triamcinolone—multiple sclerosis	2.55e-05	0.000586	CcSEcCtD
Fludarabine—Fatigue—Methylprednisolone—multiple sclerosis	2.55e-05	0.000584	CcSEcCtD
Fludarabine—Pain—Triamcinolone—multiple sclerosis	2.53e-05	0.000581	CcSEcCtD
Fludarabine—Vomiting—Mitoxantrone—multiple sclerosis	2.49e-05	0.000573	CcSEcCtD
Fludarabine—Convulsion—Prednisone—multiple sclerosis	2.48e-05	0.00057	CcSEcCtD
Fludarabine—Rash—Mitoxantrone—multiple sclerosis	2.47e-05	0.000568	CcSEcCtD
Fludarabine—Dermatitis—Mitoxantrone—multiple sclerosis	2.47e-05	0.000567	CcSEcCtD
Fludarabine—Chills—Methotrexate—multiple sclerosis	2.47e-05	0.000567	CcSEcCtD
Fludarabine—Headache—Mitoxantrone—multiple sclerosis	2.46e-05	0.000564	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	2.45e-05	0.000562	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	2.45e-05	0.000562	CcSEcCtD
Fludarabine—Myalgia—Prednisone—multiple sclerosis	2.44e-05	0.00056	CcSEcCtD
Fludarabine—Arthralgia—Prednisone—multiple sclerosis	2.44e-05	0.00056	CcSEcCtD
Fludarabine—Feeling abnormal—Triamcinolone—multiple sclerosis	2.44e-05	0.00056	CcSEcCtD
Fludarabine—Feeling abnormal—Methylprednisolone—multiple sclerosis	2.43e-05	0.000559	CcSEcCtD
Fludarabine—Alopecia—Methotrexate—multiple sclerosis	2.43e-05	0.000558	CcSEcCtD
Fludarabine—Paraesthesia—Betamethasone—multiple sclerosis	2.41e-05	0.000554	CcSEcCtD
Fludarabine—Paraesthesia—Dexamethasone—multiple sclerosis	2.41e-05	0.000554	CcSEcCtD
Fludarabine—Discomfort—Prednisone—multiple sclerosis	2.41e-05	0.000553	CcSEcCtD
Fludarabine—RRM1—Metabolism—GPC5—multiple sclerosis	2.4e-05	0.00439	CbGpPWpGaD
Fludarabine—Malnutrition—Methotrexate—multiple sclerosis	2.4e-05	0.00055	CcSEcCtD
Fludarabine—Hypersensitivity—Prednisolone—multiple sclerosis	2.37e-05	0.000544	CcSEcCtD
Fludarabine—Dyspepsia—Dexamethasone—multiple sclerosis	2.36e-05	0.000543	CcSEcCtD
Fludarabine—Dyspepsia—Betamethasone—multiple sclerosis	2.36e-05	0.000543	CcSEcCtD
Fludarabine—Body temperature increased—Triamcinolone—multiple sclerosis	2.34e-05	0.000537	CcSEcCtD
Fludarabine—Anaphylactic shock—Prednisone—multiple sclerosis	2.34e-05	0.000537	CcSEcCtD
Fludarabine—Oedema—Prednisone—multiple sclerosis	2.34e-05	0.000537	CcSEcCtD
Fludarabine—Decreased appetite—Dexamethasone—multiple sclerosis	2.34e-05	0.000536	CcSEcCtD
Fludarabine—Decreased appetite—Betamethasone—multiple sclerosis	2.34e-05	0.000536	CcSEcCtD
Fludarabine—Nausea—Mitoxantrone—multiple sclerosis	2.33e-05	0.000535	CcSEcCtD
Fludarabine—Infection—Prednisone—multiple sclerosis	2.32e-05	0.000533	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	2.32e-05	0.000532	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	2.32e-05	0.000532	CcSEcCtD
Fludarabine—Fatigue—Dexamethasone—multiple sclerosis	2.32e-05	0.000531	CcSEcCtD
Fludarabine—Fatigue—Betamethasone—multiple sclerosis	2.32e-05	0.000531	CcSEcCtD
Fludarabine—Pain—Betamethasone—multiple sclerosis	2.3e-05	0.000527	CcSEcCtD
Fludarabine—Pain—Dexamethasone—multiple sclerosis	2.3e-05	0.000527	CcSEcCtD
Fludarabine—Nervous system disorder—Prednisone—multiple sclerosis	2.29e-05	0.000526	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.27e-05	0.00415	CbGpPWpGaD
Fludarabine—Hyperhidrosis—Prednisone—multiple sclerosis	2.26e-05	0.000519	CcSEcCtD
Fludarabine—POLA1—E2F transcription factor network—MYC—multiple sclerosis	2.24e-05	0.00408	CbGpPWpGaD
Fludarabine—Anorexia—Prednisone—multiple sclerosis	2.23e-05	0.000512	CcSEcCtD
Fludarabine—Ill-defined disorder—Methotrexate—multiple sclerosis	2.22e-05	0.00051	CcSEcCtD
Fludarabine—Anaemia—Methotrexate—multiple sclerosis	2.21e-05	0.000508	CcSEcCtD
Fludarabine—Feeling abnormal—Betamethasone—multiple sclerosis	2.21e-05	0.000508	CcSEcCtD
Fludarabine—Feeling abnormal—Dexamethasone—multiple sclerosis	2.21e-05	0.000508	CcSEcCtD
Fludarabine—Hypersensitivity—Triamcinolone—multiple sclerosis	2.18e-05	0.000501	CcSEcCtD
Fludarabine—Hypersensitivity—Methylprednisolone—multiple sclerosis	2.18e-05	0.000499	CcSEcCtD
Fludarabine—Malaise—Methotrexate—multiple sclerosis	2.16e-05	0.000496	CcSEcCtD
Fludarabine—Leukopenia—Methotrexate—multiple sclerosis	2.14e-05	0.000492	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	2.13e-05	0.000489	CcSEcCtD
Fludarabine—Asthenia—Triamcinolone—multiple sclerosis	2.12e-05	0.000487	CcSEcCtD
Fludarabine—Body temperature increased—Betamethasone—multiple sclerosis	2.12e-05	0.000487	CcSEcCtD
Fludarabine—Body temperature increased—Dexamethasone—multiple sclerosis	2.12e-05	0.000487	CcSEcCtD
Fludarabine—Asthenia—Methylprednisolone—multiple sclerosis	2.12e-05	0.000486	CcSEcCtD
Fludarabine—Paraesthesia—Prednisone—multiple sclerosis	2.1e-05	0.000482	CcSEcCtD
Fludarabine—Pruritus—Triamcinolone—multiple sclerosis	2.09e-05	0.000481	CcSEcCtD
Fludarabine—Cough—Methotrexate—multiple sclerosis	2.09e-05	0.00048	CcSEcCtD
Fludarabine—Pruritus—Methylprednisolone—multiple sclerosis	2.09e-05	0.00048	CcSEcCtD
Fludarabine—Convulsion—Methotrexate—multiple sclerosis	2.08e-05	0.000476	CcSEcCtD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.07e-05	0.00379	CbGpPWpGaD
Fludarabine—Dyspepsia—Prednisone—multiple sclerosis	2.06e-05	0.000473	CcSEcCtD
Fludarabine—Myalgia—Methotrexate—multiple sclerosis	2.04e-05	0.000468	CcSEcCtD
Fludarabine—Arthralgia—Methotrexate—multiple sclerosis	2.04e-05	0.000468	CcSEcCtD
Fludarabine—Decreased appetite—Prednisone—multiple sclerosis	2.03e-05	0.000467	CcSEcCtD
Fludarabine—Rash—Prednisolone—multiple sclerosis	2.03e-05	0.000466	CcSEcCtD
Fludarabine—Dermatitis—Prednisolone—multiple sclerosis	2.03e-05	0.000465	CcSEcCtD
Fludarabine—DCK—Metabolism—CYP27B1—multiple sclerosis	2.02e-05	0.0037	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP24A1—multiple sclerosis	2.02e-05	0.0037	CbGpPWpGaD
Fludarabine—Diarrhoea—Methylprednisolone—multiple sclerosis	2.02e-05	0.000464	CcSEcCtD
Fludarabine—Fatigue—Prednisone—multiple sclerosis	2.02e-05	0.000463	CcSEcCtD
Fludarabine—Headache—Prednisolone—multiple sclerosis	2.02e-05	0.000463	CcSEcCtD
Fludarabine—Discomfort—Methotrexate—multiple sclerosis	2.01e-05	0.000462	CcSEcCtD
Fludarabine—Constipation—Prednisone—multiple sclerosis	2e-05	0.000459	CcSEcCtD
Fludarabine—Confusional state—Methotrexate—multiple sclerosis	1.97e-05	0.000452	CcSEcCtD
Fludarabine—Anaphylactic shock—Methotrexate—multiple sclerosis	1.96e-05	0.000449	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	1.94e-05	0.00355	CbGpPWpGaD
Fludarabine—Infection—Methotrexate—multiple sclerosis	1.94e-05	0.000446	CcSEcCtD
Fludarabine—Feeling abnormal—Prednisone—multiple sclerosis	1.93e-05	0.000442	CcSEcCtD
Fludarabine—Asthenia—Dexamethasone—multiple sclerosis	1.93e-05	0.000442	CcSEcCtD
Fludarabine—Asthenia—Betamethasone—multiple sclerosis	1.93e-05	0.000442	CcSEcCtD
Fludarabine—Nervous system disorder—Methotrexate—multiple sclerosis	1.92e-05	0.00044	CcSEcCtD
Fludarabine—Thrombocytopenia—Methotrexate—multiple sclerosis	1.91e-05	0.000439	CcSEcCtD
Fludarabine—Nausea—Prednisolone—multiple sclerosis	1.91e-05	0.000439	CcSEcCtD
Fludarabine—Pruritus—Dexamethasone—multiple sclerosis	1.9e-05	0.000436	CcSEcCtD
Fludarabine—Pruritus—Betamethasone—multiple sclerosis	1.9e-05	0.000436	CcSEcCtD
Fludarabine—Hyperhidrosis—Methotrexate—multiple sclerosis	1.89e-05	0.000434	CcSEcCtD
Fludarabine—Vomiting—Triamcinolone—multiple sclerosis	1.88e-05	0.000432	CcSEcCtD
Fludarabine—Vomiting—Methylprednisolone—multiple sclerosis	1.88e-05	0.000431	CcSEcCtD
Fludarabine—Rash—Triamcinolone—multiple sclerosis	1.87e-05	0.000428	CcSEcCtD
Fludarabine—Dermatitis—Triamcinolone—multiple sclerosis	1.86e-05	0.000428	CcSEcCtD
Fludarabine—Anorexia—Methotrexate—multiple sclerosis	1.86e-05	0.000428	CcSEcCtD
Fludarabine—Rash—Methylprednisolone—multiple sclerosis	1.86e-05	0.000427	CcSEcCtD
Fludarabine—Dermatitis—Methylprednisolone—multiple sclerosis	1.86e-05	0.000427	CcSEcCtD
Fludarabine—Headache—Triamcinolone—multiple sclerosis	1.85e-05	0.000426	CcSEcCtD
Fludarabine—Headache—Methylprednisolone—multiple sclerosis	1.85e-05	0.000425	CcSEcCtD
Fludarabine—DCK—Metabolism—GPC5—multiple sclerosis	1.85e-05	0.00338	CbGpPWpGaD
Fludarabine—Body temperature increased—Prednisone—multiple sclerosis	1.85e-05	0.000424	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.84e-05	0.00336	CbGpPWpGaD
Fludarabine—Diarrhoea—Dexamethasone—multiple sclerosis	1.84e-05	0.000422	CcSEcCtD
Fludarabine—Diarrhoea—Betamethasone—multiple sclerosis	1.84e-05	0.000422	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.83e-05	0.00335	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.8e-05	0.00329	CbGpPWpGaD
Fludarabine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	1.78e-05	0.000409	CcSEcCtD
Fludarabine—Nausea—Triamcinolone—multiple sclerosis	1.76e-05	0.000404	CcSEcCtD
Fludarabine—Paraesthesia—Methotrexate—multiple sclerosis	1.76e-05	0.000403	CcSEcCtD
Fludarabine—Nausea—Methylprednisolone—multiple sclerosis	1.75e-05	0.000403	CcSEcCtD
Fludarabine—Dyspnoea—Methotrexate—multiple sclerosis	1.74e-05	0.0004	CcSEcCtD
Fludarabine—Hypersensitivity—Prednisone—multiple sclerosis	1.72e-05	0.000396	CcSEcCtD
Fludarabine—Dyspepsia—Methotrexate—multiple sclerosis	1.72e-05	0.000395	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.71e-05	0.00313	CbGpPWpGaD
Fludarabine—Vomiting—Dexamethasone—multiple sclerosis	1.71e-05	0.000392	CcSEcCtD
Fludarabine—Vomiting—Betamethasone—multiple sclerosis	1.71e-05	0.000392	CcSEcCtD
Fludarabine—Decreased appetite—Methotrexate—multiple sclerosis	1.7e-05	0.00039	CcSEcCtD
Fludarabine—Rash—Dexamethasone—multiple sclerosis	1.69e-05	0.000389	CcSEcCtD
Fludarabine—Rash—Betamethasone—multiple sclerosis	1.69e-05	0.000389	CcSEcCtD
Fludarabine—Dermatitis—Betamethasone—multiple sclerosis	1.69e-05	0.000388	CcSEcCtD
Fludarabine—Dermatitis—Dexamethasone—multiple sclerosis	1.69e-05	0.000388	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	1.69e-05	0.000387	CcSEcCtD
Fludarabine—Fatigue—Methotrexate—multiple sclerosis	1.69e-05	0.000387	CcSEcCtD
Fludarabine—Headache—Betamethasone—multiple sclerosis	1.68e-05	0.000386	CcSEcCtD
Fludarabine—Headache—Dexamethasone—multiple sclerosis	1.68e-05	0.000386	CcSEcCtD
Fludarabine—Asthenia—Prednisone—multiple sclerosis	1.68e-05	0.000385	CcSEcCtD
Fludarabine—Pain—Methotrexate—multiple sclerosis	1.67e-05	0.000384	CcSEcCtD
Fludarabine—Pruritus—Prednisone—multiple sclerosis	1.66e-05	0.00038	CcSEcCtD
Fludarabine—POLA1—G1/S Transition—MYC—multiple sclerosis	1.62e-05	0.00296	CbGpPWpGaD
Fludarabine—Feeling abnormal—Methotrexate—multiple sclerosis	1.61e-05	0.00037	CcSEcCtD
Fludarabine—Diarrhoea—Prednisone—multiple sclerosis	1.6e-05	0.000367	CcSEcCtD
Fludarabine—Nausea—Betamethasone—multiple sclerosis	1.6e-05	0.000366	CcSEcCtD
Fludarabine—Nausea—Dexamethasone—multiple sclerosis	1.6e-05	0.000366	CcSEcCtD
Fludarabine—Body temperature increased—Methotrexate—multiple sclerosis	1.55e-05	0.000355	CcSEcCtD
Fludarabine—DCK—Metabolism—RRM1—multiple sclerosis	1.53e-05	0.0028	CbGpPWpGaD
Fludarabine—Vomiting—Prednisone—multiple sclerosis	1.49e-05	0.000341	CcSEcCtD
Fludarabine—Rash—Prednisone—multiple sclerosis	1.47e-05	0.000338	CcSEcCtD
Fludarabine—Dermatitis—Prednisone—multiple sclerosis	1.47e-05	0.000338	CcSEcCtD
Fludarabine—POLA1—S Phase—MYC—multiple sclerosis	1.47e-05	0.00269	CbGpPWpGaD
Fludarabine—Headache—Prednisone—multiple sclerosis	1.47e-05	0.000336	CcSEcCtD
Fludarabine—Hypersensitivity—Methotrexate—multiple sclerosis	1.44e-05	0.000331	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.41e-05	0.00258	CbGpPWpGaD
Fludarabine—Asthenia—Methotrexate—multiple sclerosis	1.4e-05	0.000322	CcSEcCtD
Fludarabine—Nausea—Prednisone—multiple sclerosis	1.39e-05	0.000319	CcSEcCtD
Fludarabine—Pruritus—Methotrexate—multiple sclerosis	1.38e-05	0.000317	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—MYC—multiple sclerosis	1.37e-05	0.0025	CbGpPWpGaD
Fludarabine—Diarrhoea—Methotrexate—multiple sclerosis	1.34e-05	0.000307	CcSEcCtD
Fludarabine—Vomiting—Methotrexate—multiple sclerosis	1.24e-05	0.000285	CcSEcCtD
Fludarabine—Rash—Methotrexate—multiple sclerosis	1.23e-05	0.000283	CcSEcCtD
Fludarabine—Dermatitis—Methotrexate—multiple sclerosis	1.23e-05	0.000283	CcSEcCtD
Fludarabine—Headache—Methotrexate—multiple sclerosis	1.22e-05	0.000281	CcSEcCtD
Fludarabine—Nausea—Methotrexate—multiple sclerosis	1.16e-05	0.000266	CcSEcCtD
Fludarabine—RRM1—Metabolism—BCHE—multiple sclerosis	1.14e-05	0.00209	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.05e-05	0.00192	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.04e-05	0.00189	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.03e-05	0.00189	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.01e-05	0.00185	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	9.64e-06	0.00176	CbGpPWpGaD
Fludarabine—DCK—Metabolism—BCHE—multiple sclerosis	8.81e-06	0.00161	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—APOE—multiple sclerosis	6.88e-06	0.00126	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—MAPK1—multiple sclerosis	6.56e-06	0.0012	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—POMC—multiple sclerosis	5.91e-06	0.00108	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ALB—multiple sclerosis	5.39e-06	0.000985	CbGpPWpGaD
Fludarabine—DCK—Metabolism—APOE—multiple sclerosis	5.3e-06	0.000968	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MYC—multiple sclerosis	5.01e-06	0.000916	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	4.9e-06	0.000896	CbGpPWpGaD
Fludarabine—DCK—Metabolism—POMC—multiple sclerosis	4.55e-06	0.000831	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MYC—multiple sclerosis	4.48e-06	0.000819	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MAPK1—multiple sclerosis	4.38e-06	0.000801	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ALB—multiple sclerosis	4.15e-06	0.000758	CbGpPWpGaD
